64 related articles for article (PubMed ID: 15621777)
1. Activation of the Jak3 pathway and myeloid differentiation.
Mangan JK; Reddy EP
Leuk Lymphoma; 2005 Jan; 46(1):21-7. PubMed ID: 15621777
[TBL] [Abstract][Full Text] [Related]
2. Activation of the Jak3 pathway is associated with granulocytic differentiation of myeloid precursor cells.
Rane SG; Mangan JK; Amanullah A; Wong BC; Vora RK; Liebermann DA; Hoffman B; Graña X; Reddy EP
Blood; 2002 Oct; 100(8):2753-62. PubMed ID: 12351382
[TBL] [Abstract][Full Text] [Related]
3. Granulocyte colony-stimulating factor-induced upregulation of Jak3 transcription during granulocytic differentiation is mediated by the cooperative action of Sp1 and Stat3.
Mangan JK; Tantravahi RV; Rane SG; Reddy EP
Oncogene; 2006 Apr; 25(17):2489-99. PubMed ID: 16518416
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms associated with IL-6-induced up-regulation of Jak3 and its role in monocytic differentiation.
Mangan JK; Rane SG; Kang AD; Amanullah A; Wong BC; Reddy EP
Blood; 2004 Jun; 103(11):4093-101. PubMed ID: 14976041
[TBL] [Abstract][Full Text] [Related]
5. Importance of MEK-1/-2 signaling in monocytic and granulocytic differentiation of myeloid cell lines.
Miranda MB; McGuire TF; Johnson DE
Leukemia; 2002 Apr; 16(4):683-92. PubMed ID: 11960350
[TBL] [Abstract][Full Text] [Related]
6. Constitutive activation of JAK3/STAT3 in colon carcinoma tumors and cell lines: inhibition of JAK3/STAT3 signaling induces apoptosis and cell cycle arrest of colon carcinoma cells.
Lin Q; Lai R; Chirieac LR; Li C; Thomazy VA; Grammatikakis I; Rassidakis GZ; Zhang W; Fujio Y; Kunisada K; Hamilton SR; Amin HM
Am J Pathol; 2005 Oct; 167(4):969-80. PubMed ID: 16192633
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of JAK3 induces apoptosis and decreases anaplastic lymphoma kinase activity in anaplastic large cell lymphoma.
Amin HM; Medeiros LJ; Ma Y; Feretzaki M; Das P; Leventaki V; Rassidakis GZ; O'Connor SL; McDonnell TJ; Lai R
Oncogene; 2003 Aug; 22(35):5399-407. PubMed ID: 12934099
[TBL] [Abstract][Full Text] [Related]
8. Restoration of shp1 expression by 5-AZA-2'-deoxycytidine is associated with downregulation of JAK3/STAT3 signaling in ALK-positive anaplastic large cell lymphoma.
Han Y; Amin HM; Frantz C; Franko B; Lee J; Lin Q; Lai R
Leukemia; 2006 Sep; 20(9):1602-9. PubMed ID: 16871283
[TBL] [Abstract][Full Text] [Related]
9. Expression of Janus kinase 3 in human endothelial and other non-lymphoid and non-myeloid cells.
Verbsky JW; Bach EA; Fang YF; Yang L; Randolph DA; Fields LE
J Biol Chem; 1996 Jun; 271(24):13976-80. PubMed ID: 8662778
[TBL] [Abstract][Full Text] [Related]
10. Granulocytic differentiation of myeloid progenitor cells by p130, the retinoblastoma tumor suppressor homologue.
Mori A; Higashi H; Hoshikawa Y; Imamura M; Asaka M; Hatakeyama M
Oncogene; 1999 Nov; 18(46):6209-21. PubMed ID: 10597219
[TBL] [Abstract][Full Text] [Related]
11. Differential substrate recognition capabilities of Janus family protein tyrosine kinases within the interleukin 2 receptor (IL2R) system: Jak3 as a potential molecular target for treatment of leukemias with a hyperactive Jak-Stat signaling machinery.
Witthuhn BA; Williams MD; Kerawalla H; Uckun FM
Leuk Lymphoma; 1999 Jan; 32(3-4):289-97. PubMed ID: 10037026
[TBL] [Abstract][Full Text] [Related]
12. Dissociation of the Jak kinase pathway from G-CSF receptor signaling in neutrophils.
Avalos BR; Parker JM; Ware DA; Hunter MG; Sibert KA; Druker BJ
Exp Hematol; 1997 Feb; 25(2):160-8. PubMed ID: 9015216
[TBL] [Abstract][Full Text] [Related]
13. p120 nucleolar-proliferating antigen is a direct target of G-CSF signaling during myeloid differentiation.
Khanna-Gupta A; Sun H; Zibello T; Lozovatsky L; Ghosh PK; Link DC; McLemore ML; Berliner N
J Leukoc Biol; 2006 May; 79(5):1011-21. PubMed ID: 16641140
[TBL] [Abstract][Full Text] [Related]
14. JAK3, STAT, and MAPK signaling pathways as novel molecular targets for the tyrphostin AG-490 regulation of IL-2-mediated T cell response.
Wang LH; Kirken RA; Erwin RA; Yu CR; Farrar WL
J Immunol; 1999 Apr; 162(7):3897-904. PubMed ID: 10201908
[TBL] [Abstract][Full Text] [Related]
15. Jak3 activation is significantly associated with ALK expression in anaplastic large cell lymphoma.
Lai R; Rassidakis GZ; Lin Q; Atwell C; Medeiros LJ; Amin HM
Hum Pathol; 2005 Sep; 36(9):939-44. PubMed ID: 16153455
[TBL] [Abstract][Full Text] [Related]
16. STAT3-mediated differentiation and survival and of myeloid cells in response to granulocyte colony-stimulating factor: role for the cyclin-dependent kinase inhibitor p27(Kip1).
de Koning JP; Soede-Bobok AA; Ward AC; Schelen AM; Antonissen C; van Leeuwen D; Löwenberg B; Touw IP
Oncogene; 2000 Jul; 19(29):3290-8. PubMed ID: 10918585
[TBL] [Abstract][Full Text] [Related]
17. p55Cdc/cdc20 overexpression promotes early g1/s transition in myeloid cells.
Lin ML; Sakamoto KM
Stem Cells; 2001; 19(3):205-11. PubMed ID: 11359945
[TBL] [Abstract][Full Text] [Related]
18. JAK3: a novel JAK kinase associated with terminal differentiation of hematopoietic cells.
Rane SG; Reddy EP
Oncogene; 1994 Aug; 9(8):2415-23. PubMed ID: 7518579
[TBL] [Abstract][Full Text] [Related]
19. Murine JAK3 is preferentially expressed in hematopoietic tissues and lymphocyte precursor cells.
Gurniak CB; Berg LJ
Blood; 1996 Apr; 87(8):3151-60. PubMed ID: 8605329
[TBL] [Abstract][Full Text] [Related]
20. Developmental defects of lymphoid cells in Jak3 kinase-deficient mice.
Park SY; Saijo K; Takahashi T; Osawa M; Arase H; Hirayama N; Miyake K; Nakauchi H; Shirasawa T; Saito T
Immunity; 1995 Dec; 3(6):771-82. PubMed ID: 8777722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
